Swedbank AB Sells 8,000 Shares of Masimo Corporation $MASI

Swedbank AB cut its holdings in Masimo Corporation (NASDAQ:MASI) by 11.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 59,500 shares of the medical equipment provider’s stock after selling 8,000 shares during the period. Swedbank AB’s holdings in Masimo were worth $7,739,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in MASI. Global Retirement Partners LLC bought a new stake in shares of Masimo in the 4th quarter worth about $27,000. Torren Management LLC bought a new stake in shares of Masimo in the 4th quarter worth about $35,000. Smartleaf Asset Management LLC increased its holdings in shares of Masimo by 80.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 136 shares during the last quarter. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Masimo in the 4th quarter worth about $44,000. Finally, Advisory Services Network LLC bought a new stake in shares of Masimo in the 3rd quarter worth about $46,000. 85.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a report on Tuesday, February 17th. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a report on Tuesday, February 17th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Wolfe Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Nine equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $180.40.

Masimo Stock Performance

Shares of NASDAQ:MASI opened at $178.67 on Wednesday. The company has a market capitalization of $9.36 billion, a price-to-earnings ratio of -16.95, a PEG ratio of 1.81 and a beta of 1.13. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.00. The firm’s 50-day moving average is $178.25 and its 200 day moving average is $157.64. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.